MedTrace Logo

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

NCT07014618 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2025-12-17

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.

Conditions

Interventions

OTHER

Pre & Post Surveys

As part of this intervention, patients will complete a pre-treatment questionnaire at the time of consent, which can be administered in person, over the phone, or through the mHealth mobile app, based on their preference. One month after treatment, patients will complete a post-treatment questionnaire using their chosen method. At the six-month mark, patients will complete an additional post-treatment questionnaire along with the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) survey.

OTHER

Opt Out of Questionnaire

As part of this intervention, patients declined to participate in the optional questionnaire. However, their data will still be collected through chart review and will be compared to the data of patients who accepted both the questionnaire and navigation services.

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • Radiation Therapy Oncology Group

    collaborator NETWORK

  • Susan G. Komen Breast Cancer Foundation

    collaborator OTHER

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Shearwood McClelland III, MD · OU Health Stephenson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-16
Primary Completion
2029-10-31
Completion
2030-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07014618 on ClinicalTrials.gov